Publication:

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Date

Date

Date
2014
Journal Article
Published version

Citations

Citation copied

Bramante, S., Koski, A., Kipar, A., Diaconu, I., Liikanen, I., Hemminki, O., Vassilev, L., Parviainen, S., Cerullo, V., Pesonen, S. K., Oksanen, M., Heiskanen, R., Rouvinen-Lagerström, N., Merisalo-Soikkeli, M., Hakonen, T., Joensuu, T., Kanerva, A., Pesonen, S., & Hemminki, A. (2014). Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. International Journal of Cancer, 135, 720–730. https://doi.org/10.1002/ijc.28696

Abstract

Abstract

Abstract

Sarcomas are a relatively rare cancer, but often incurable at the late metastatic stage. Oncolytic immunotherapy has gained attention over the past years, and a wide range of oncolytic viruses have been delivered via intratumoral injection with positive safety and promising efficacy data. Here, we report preclinical and clinical results from treatment of sarcoma with oncolytic adenovirus Ad5/3-D24-GMCSF (CGTG-102). Ad5/3-D24-GMCSF is a serotype chimeric oncolytic adenovirus coding for human granulocyte-macrophage colony-stimulating fa

Metrics

Downloads

1 since deposited on 2014-01-13
Acq. date: 2025-11-13

Views

98 since deposited on 2014-01-13
97last week
Acq. date: 2025-11-13

Additional indexing

Creators (Authors)

  • Bramante, S
    affiliation.icon.alt
  • Koski, A
    affiliation.icon.alt
  • Kipar, A
    affiliation.icon.alt
  • Diaconu, I
    affiliation.icon.alt
  • Liikanen, I
    affiliation.icon.alt
  • Hemminki, O
    affiliation.icon.alt
  • Vassilev, L
    affiliation.icon.alt
  • Parviainen, S
    affiliation.icon.alt
  • Cerullo, V
    affiliation.icon.alt
  • Pesonen, S K
    affiliation.icon.alt
  • Oksanen, M
    affiliation.icon.alt
  • Heiskanen, R
    affiliation.icon.alt
  • Rouvinen-Lagerström, N
    affiliation.icon.alt
  • Merisalo-Soikkeli, M
    affiliation.icon.alt
  • Hakonen, T
    affiliation.icon.alt
  • Joensuu, T
    affiliation.icon.alt
  • Kanerva, A
    affiliation.icon.alt
  • Pesonen, S
    affiliation.icon.alt
  • Hemminki, A
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
135

Number

Number

Number
3

Page range/Item number

Page range/Item number

Page range/Item number
720

Page end

Page end

Page end
730

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

Cancer Research, Oncology

Language

Language

Language
English

Publication date

Publication date

Publication date
2014

Date available

Date available

Date available
2014-01-13

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
0020-7136

OA Status

OA Status

OA Status
Closed

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

1 since deposited on 2014-01-13
Acq. date: 2025-11-13

Views

98 since deposited on 2014-01-13
97last week
Acq. date: 2025-11-13

Citations

Citation copied

Bramante, S., Koski, A., Kipar, A., Diaconu, I., Liikanen, I., Hemminki, O., Vassilev, L., Parviainen, S., Cerullo, V., Pesonen, S. K., Oksanen, M., Heiskanen, R., Rouvinen-Lagerström, N., Merisalo-Soikkeli, M., Hakonen, T., Joensuu, T., Kanerva, A., Pesonen, S., & Hemminki, A. (2014). Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. International Journal of Cancer, 135, 720–730. https://doi.org/10.1002/ijc.28696

Closed
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image